Yüklüyor......
The Antidepressant Agomelatine Improves Memory Deterioration and Upregulates CREB and BDNF Gene Expression Levels in Unpredictable Chronic Mild Stress (UCMS)-Exposed Mice
Agomelatine, a novel antidepressant with established clinical efficacy, acts as an agonist of melatonergic MT 1 and MT 2 receptors and as an antagonist of 5-HT 2C receptors. The present study was undertaken to investigate whether chronic treatment with agomelatine would block unpredictable chronic m...
Kaydedildi:
Asıl Yazarlar: | , , , , , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
AboutScience Srl
2014-01-01
|
Seri Bilgileri: | Drug Target Insights |
Online Erişim: | https://doi.org/10.4137/DTI.S13870 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|